BSI 22/30445135 DC:2022 Edition
$13.70
BS ISO 23217. Injection systems intended for self-administration by paediatric patients. Guidance for design
Published By | Publication Date | Number of Pages |
BSI | 2022 | 46 |
PDF Catalog
PDF Pages | PDF Title |
---|---|
6 | Foreword |
7 | Introduction |
9 | 1 Scope 2 Normative references |
10 | 3 Terms and definitions |
13 | 4 Considerations for design inputs 4.1 General 4.2 Risk assessment and usability engineering 4.2.1 Risk assessment 4.2.2 Usability engineering 4.3 Determination of the intended demographic population |
14 | 4.4 Considerations for the determination of requirements for the design of medical devices specific to paediatric users 4.4.1 Considerations in relation to risk (risk-based approach to design) 4.4.2 Considerations in relation to human factors |
15 | 4.4.3 Considerations in relation to design attributes |
19 | 4.4.4 Considerations for accompanying documentation 5 Development of the design specification |
20 | 6 Design verification and validation 6.1 General 6.2 Design verification 6.3 Design validation 6.3.1 General 6.3.2 Usability evaluations (also known as usability tests or user studies) |
21 | 6.3.3 Clinical evaluation |
23 | Annex€A (informative) Additional considerations for the “paediatric population” |
44 | Bibliography |